SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Monday reported a loss of $136.1 million in its first quarter.
The San Diego-based company said it had a loss of $1.76 per share.
The results did not meet Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.
The drug developer posted revenue of $41.4 million in the period, which also did not meet Street forecasts. Eight analysts surveyed by Zacks expected $42.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
